Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vivus Inc (VVUSQ)

Vivus Inc (VVUSQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,098
  • Shares Outstanding, K 17,867
  • Annual Sales, $ 69,760 K
  • Annual Income, $ -31,500 K
  • 60-Month Beta -3.41
  • Price/Sales 0.03
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade VVUSQ with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.14
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 06/30/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0654 +79.51%
on 11/16/20
0.3800 -69.11%
on 11/12/20
-0.2526 (-68.27%)
since 11/11/20
3-Month
0.0654 +79.51%
on 11/16/20
0.5000 -76.52%
on 10/09/20
-0.0982 (-45.55%)
since 09/11/20
52-Week
0.0654 +79.51%
on 11/16/20
4.5500 -97.42%
on 03/31/20
-2.7026 (-95.84%)
since 12/11/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3 clinical trials for the treatment of obesity...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1285
1st Resistance Point 0.1229
Last Price 0.1174
1st Support Level 0.1114
2nd Support Level 0.1055
3rd Support Level N/A

See More

52-Week High 4.5500
Fibonacci 61.8% 2.8369
Fibonacci 50% 2.3077
Fibonacci 38.2% 1.7785
Last Price 0.1174
52-Week Low 0.0654

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar